Hepatitis B virus cccDNA: Formation, regulation and therapeutic potential
Related Experiment Video
Updated: Dec 20, 2025

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
1State Key Laboratory of Virology and Hubei Province Key Laboratory of Allergy and Immunology, School of Basic Medical Sciences, Wuhan University, Wuhan, China.
Insights
Hepatitis B virus (HBV) infection affects millions globally. This review explores HBV covalently closed circular DNA (cccDNA) formation and regulation, discussing strategies for its eradication to potentially cure chronic HBV.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Chronic Hepatitis B virus (HBV) infection impacts over 257 million people worldwide.
- Current antiviral therapies manage HBV replication but do not offer a cure.
- HBV establishes a persistent cccDNA minichromosome in hepatocytes, a key barrier to eradication.
Purpose of the Study:
- To review the mechanisms of HBV covalently closed circular DNA (cccDNA) formation.
- To summarize regulatory pathways controlling cccDNA.
- To discuss potential therapeutic strategies targeting cccDNA for HBV eradication.
Main Methods:
- Comprehensive literature review of HBV cccDNA formation and regulation.
- Analysis of current and emerging therapeutic approaches targeting cccDNA.
- Synthesis of knowledge on cccDNA persistence and host interactions.
Main Results:
- Detailed overview of the molecular processes involved in cccDNA establishment and maintenance.
- Identification of key host factors and viral proteins influencing cccDNA stability.
- Exploration of diverse strategies, including gene editing and host immune modulation, for cccDNA targeting.
Conclusions:
- HBV cccDNA represents a critical obstacle to achieving a functional cure for chronic Hepatitis B.
- Targeting cccDNA formation, maintenance, or clearance is essential for developing curative therapies.
- Further research into cccDNA biology and innovative therapeutic strategies is crucial for HBV eradication.
Abstract:
Hepatitis B virus (HBV) infection remains a major public health concern worldwide with about 257 million individuals chronically infected. Current therapies can effectively control HBV replication and slow down disease progress, but cannot cure HBV infection. Upon infection, HBV establishes a pool of covalently closed circular DNA (cccDNA) in the nucleus of infected hepatocytes. The cccDNA exists as a minichromosome and resists to antivirals, thus a therapeutic eradication of cccDNA from the infected cells remains unattainable. In this review, we summarize the state of knowledge on the mechanisms underlying cccDNA formation and regulation, and discuss the possible strategies that may contribute to the eradication of HBV through targeting cccDNA.
Related Concept Videos
Cell Specific Gene Expression
Regulation of Hematopoietic Stem Cells
Viruses with RNA Genomes
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...

